Trial Profile
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs DHA-paclitaxel (Primary) ; Dacarbazine
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- Sponsors American Regent
- 16 Mar 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 22 Aug 2007 Status change from recruiting to in progress.